FDA Inspection
OneBlood, Inc.OneBlood, Inc. – FDA Inspection, Apr 18, 2019
Record Details
This FDA Inspection record concerns OneBlood, Inc., with an inspection on April 18, 2019, issued by the Center for Biologics Evaluation and Research, covering biologics.
View Company Profile
ID · c74d55de-e464-4845-941a-b76cf7035d6d
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1086790
- FDA center
- Biologics
- Project area
- Blood and Blood Products
- Outcome
- Form 483 issued
FDA Citations
1- 21 CFR 606.40(a)(1)Provide space for examination
Full citation text and observation details available on the Dashboard.
Other FDA inspections of OneBlood, Inc.
7| Date | Classification | Office | Project area |
|---|---|---|---|
| January 23, 2026 | NAI | Blood and Blood Products | |
| March 23, 2023 | NAI | Center for Biologics Evaluation and Research | Vaccines and Allergenic Products |
| February 3, 2017 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| June 23, 2015 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| December 12, 2012 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for OneBlood, Inc.
- FDA Inspection 1303580 - 2026-01-23
- FDA Inspection 1204182 - 2023-03-23
- FDA Inspection 1012284 - 2017-02-03
- FDA Inspection 932398 - 2015-06-23
- FDA Inspection 811064 - 2012-12-12
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.